Platelet-rich plasma has been used for several years in a variety of ways, and now breaking into orthopedic care, according to a story published in AAOS Now.
Several leading physicians discussed PRP use at the PRP Forum held as part of the AAOS annual meeting in February.
PRP is controversial with orthopedic applications because studies differ as to whether it has any benefit over other treatments. The preparation for PRP can vary by the amount of blood used and the efficacy of platelet recovery, presences of white or red blood cells, platelet activation with thrombin and the level of fibrin production, according to the report.
PRP use is common among professional athletes and was recently declared a reasonable treatment by the World Anti-Doping Agency. The available data currently focuses on PRP for chronic tendinopathy, not acute injuries, and the studies that do exist show contrary results. Freddie H. Fu, MD, an orthopedic surgeon with the University of Pittsburgh Medical Center, said the trend toward PRP use should be driven by science, not the market.
Read the report on PRP.
Related Articles on PRP:
AAOS: PRP an Unproven Option for Orthopedic Treatment
Rush University Researchers to Study PRP for Knee Osteoarthritis
Dr. Jeffrey Traina: PRP After Total Knee Replacement Could Reduce Blood Loss
Several leading physicians discussed PRP use at the PRP Forum held as part of the AAOS annual meeting in February.
PRP is controversial with orthopedic applications because studies differ as to whether it has any benefit over other treatments. The preparation for PRP can vary by the amount of blood used and the efficacy of platelet recovery, presences of white or red blood cells, platelet activation with thrombin and the level of fibrin production, according to the report.
PRP use is common among professional athletes and was recently declared a reasonable treatment by the World Anti-Doping Agency. The available data currently focuses on PRP for chronic tendinopathy, not acute injuries, and the studies that do exist show contrary results. Freddie H. Fu, MD, an orthopedic surgeon with the University of Pittsburgh Medical Center, said the trend toward PRP use should be driven by science, not the market.
Read the report on PRP.
Related Articles on PRP:
AAOS: PRP an Unproven Option for Orthopedic Treatment
Rush University Researchers to Study PRP for Knee Osteoarthritis
Dr. Jeffrey Traina: PRP After Total Knee Replacement Could Reduce Blood Loss